Mark Stovsky, MD, MBA, FACS

is the Chief Medical Officer at Cleveland Diagnostics. His clinical expertise and research focuses include the management of prostate cancer and benign prostate disease, diagnostic biomarkers for cancer and other diseases, and medical economics. Prior to Cleveland Diagnostics, Mark served as Sr. Director for Emerging Business at Cleveland Clinic Ventures, Science and Technology Innovations Officer at Cleveland Clinic Innovations, as a Staff Urologist in the Cleveland Clinic Glickman Urological and Kidney, and as an Associate Professor of Surgery in the CCF Lerner School of Medicine.